
Claude designs protein binders for scorpion neurotoxins in lab tests
Of 211 designs tested, 17 bound their targets; the strongest pair targeted Cn2, but antivenom effect is still untested.
6 stories, newest first · one card per story

Of 211 designs tested, 17 bound their targets; the strongest pair targeted Cn2, but antivenom effect is still untested.

Terms were undisclosed; the four-year-old startup had reportedly raised about $20 million by 2025.

Lawmakers proposed bills directing DHS and CISA to protect biotech infrastructure and biological data.

A Latent Space essay argues AI cheapens scientific thinking while biotech foundries still gate physical experiments.

Enveda raised a $311 million Series E at a $2 billion valuation to advance AI-discovered, nature-derived drugs into trials.

Anthropic confirms it runs a wet biology lab where AI models conduct physical experiments, raising biosecurity and customer-competition concerns.
Today 1.6K readers · 2.4K views · 775 reads · all time 189K views